
Kodiak Sciences is a biopharmaceutical company dedicated to developing transformative therapeutics for high prevalence retinal diseases. Utilizing its innovative ABC Platform™, which merges antibody-based and chemistry-based therapies, Kodiak focuses on creating next-generation medicines like tarcocimab, KSI-501, and KSI-101 to address unmet needs in retinal vascular and inflammatory diseases. The company fosters a culture of curiosity, creativity, compassion, and courage, aiming to make a significant impact in the field of ophthalmic therapeutics.
Kodiak Sciences is a growing, fast-growing biotechnology company specializing in ophthalmology with a focus on Antibody Biopolymer Conjugate Drug (ABCD) platform for technology development. They are seeking a Polymer Chemist to join their Polymer Sciences Team and develop new technologies in their research engine.
Kodiak Sciences is a biopharmaceutical company dedicated to developing transformative therapeutics for high prevalence retinal diseases. Utilizing its innovative ABC Platform™, which merges antibody-based and chemistry-based therapies, Kodiak focuses on creating next-generation medicines like tarcocimab, KSI-501, and KSI-101 to address unmet needs in retinal vascular and inflammatory diseases. The company fosters a culture of curiosity, creativity, compassion, and courage, aiming to make a significant impact in the field of ophthalmic therapeutics.